Amedeo's Top 20

Amedeo Smart

Independent Medical Education


10 December 2018

Multidisciplinary Journal Club

  1. Buchbinder R, van Tulder M, Oberg B, Costa LM, et al.
    Low back pain: a call for action.
    Lancet 2018.

  1. Bolhuis MS, Akkerman OW, Sturkenboom MGG, Ghimire S, et al.
    Linezolid-based Regimens for Multidrug-resistant Tuberculosis (TB): A Systematic Review to Establish or Revise the Current Recommended Dose for TB Treatment.
    Clin Infect Dis 2018;67:S327-S335.

  2. Seto WK, Lo YR, Pawlotsky JM, Yuen MF, et al.
    Chronic hepatitis B virus infection.
    Lancet 2018;392:2313-2324.

  3. Sandborn WJ, Cyrille M, Hansen MB, Feagan BG, et al.
    Efficacy and Safety of Abrilumab in a Randomized, Placebo-Controlled Trial for Moderate to Severe Ulcerative Colitis.
    Gastroenterology 2018.

  4. Charytan DM, Himmelfarb J, Ikizler TA, Raj DS, et al.
    Safety and cardiovascular efficacy of spironolactone in dialysis-dependent ESRD (SPin-D): a randomized, placebo-controlled, multiple dosage trial.
    Kidney Int 2018.

  1. Sturkenboom MGG, Simbar N, Akkerman OW, Ghimire S, et al.
    Amikacin Dosing for MDR Tuberculosis: A Systematic Review to Establish or Revise the Current Recommended Dose for Tuberculosis Treatment.
    Clin Infect Dis 2018;67:S303-S307.

  2. Luster M, Aktolun C, Amendoeira I, Barczynski M, et al.
    European perspective on the 2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer. Proceedings of an interactive international symposium.
    Thyroid 2018.

  3. Stokes W, Parkins MD, Parfitt ECT, Ruiz JC, et al.
    Incidence and Outcomes of Staphylococcus aureus Bacteriuria: A Population-based Study.
    Clin Infect Dis 2018.

  4. Beckmann K, Garmo H, Adolfsson J, Bosco C, et al.
    Androgen Deprivation Therapies and Changes in Comorbidity: A Comparison of Gonadotropin-releasing Hormone Agonists and Antiandrogen Monotherapy as Primary Therapy in Men with High-risk Prostate Cancer.
    Eur Urol 2018.

  5. Srivastava S, Deshpande D, Magombedze G, Gumbo T, et al.
    Efficacy Versus Hepatotoxicity of High-dose Rifampin, Pyrazinamide, and Moxifloxacin to Shorten Tuberculosis Therapy Duration: There Is Still Fight in the Old Warriors Yet!
    Clin Infect Dis 2018;67:S359-S364.

  1. Srivastava S, Deshpande D, Nuermberger E, Lee PS, et al.
    The Sterilizing Effect of Intermittent Tedizolid for Pulmonary Tuberculosis.
    Clin Infect Dis 2018;67:S336-S341.

  2. Loarec A, Carnimeo V, Molfino L, Kizito W, et al.
    Extremely Low Hepatitis C prevalence among HIV co-infected individuals in 4 countries in sub-Saharan Africa.
    AIDS 2018.

  3. Mann J, Reeves HL, Feldstein AE.
    Liquid biopsy for liver diseases.
    Gut 2018;67:2204-2212.

  4. Sinha P, Davis J, Saag L, Wanke C, et al.
    Undernutrition and Tuberculosis: Public Health Implications.
    J Infect Dis 2018.

  5. Javaherian K, Newman BM, Weng H, Hassenstab J, et al.
    Examining the Complicated Relationship Between Depressive Symptoms and Cognitive Impairment in Preclinical Alzheimer Disease.
    Alzheimer Dis Assoc Disord 2018.

  1. Van Dyk K, Crespi CM, Bower JE, Castellon SA, et al.
    The cognitive effects of endocrine therapy in survivors of breast cancer: A prospective longitudinal study up to 6 years after treatment.
    Cancer 2018.

  2. Sommer RJ, Nazif T, Privitera L, Robbins BT, et al.
    Retrospective review of thienopyridine therapy in migraineurs with patent foramen ovale.
    Neurology 2018;91:1002-1009.

  3. Bischof N, Hirsch HH, Wehmeier C, Amico P, et al.
    Reducing calcineurin inhibitor first for treating BK polyomavirus replication after kidney transplantation: long-term outcomes.
    Nephrol Dial Transplant 2018.

  4. .
    Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    Lancet 2018;392:1684-1735.

  5. Ruhstaller T, Giobbie-Hurder A, Colleoni M, Jensen MB, et al.
    Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor-Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial.
    J Clin Oncol 2018.


more..


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016